3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
19
Leukemia
17
Leukemia, Myeloid, Acute
15
Lymphoma
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Follicular
13
Leukemia, Lymphocytic, Chronic, B-Cell
13
Lymphoma, Non-Hodgkin
12
Lymphoma, Mantle-Cell
12
Lymphoma, B-Cell, Marginal Zone
12
Leukemia, Myeloid, Chronic-Phase
11
Multiple Myeloma
10
Hodgkin Disease
10
Lymphoma, Large B-Cell, Diffuse
9
Burkitt Lymphoma
9
Anemia, Refractory, with Excess of Blasts
9
Anemia, Refractory
9
Lymphoma, Large-Cell, Immunoblastic
8
Leukemia, Myeloid, Accelerated Phase
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Recurrence
7
Primary Myelofibrosis
7
Myeloproliferative Disorders
7
Leukemia, Myelomonocytic, Chronic
7
Dendritic Cell Sarcoma, Interdigitating
7
Congenital Abnormalities
7
Blast Crisis
7
Neoplasms, Plasma Cell
6
Leukemia, Biphenotypic, Acute
6
Leukemia, Myelomonocytic, Juvenile
5
Interventions
tagraxofusp
2
Mycophenolic Acid
2
Cyclophosphamide
2
merphos
1
lorvotuzumab mertansine
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Thiotepa
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Methotrexate
1
Cyclosporins
1
Cyclosporine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Blastic Plasmacytoid Dendritic Cell Neoplasm
×
Cord Blood Stem Cell Transplantation
×
Clear all
No trials found.